Approval · Notice of Compliance 22558 · 2019
UPTRAVI: Notice of Compliance 22558
Issued August 20, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22558
- Date
- August 20, 2019
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Updates to the carton labels, product monograph and the package insert
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| UPTRAVI | Not yet assigned | — |